Sarah Bos

83 Hemostatic complications in hepatobiliary surgery 5 81. Blasi A, Hernandez V, Fernandez J, Colmenero J, Beltran J, Garcia-Valdecasas JC, et al. Venous Thrombotic Events After Liver Transplantation. Clin Appl Thromb. 2016 Nov 28;(Epub ahead of print):107602961668047. 82. Annamalai A, Kim I, Sundaram V, Klein A. Incidence and risk factors of deep vein thrombosis after liver transplantation. Vol. 46, Transplantation Proceedings. 2014. p. 3564–9. 83. Salami A, Qureshi W, Kuriakose P, Moonka D, Yoshida A, Abouljoud M. Frequency and predictors of venous thromboembolism in orthotopic liver transplant recipients: A single-center retrospective review. Vol. 45, Transplantation Proceedings. 2013. p. 315– 9. 84. Yip J, Bruno DA, Burmeister C, Kazimi M, Yoshida A, Abouljoud MS, et al. Deep Vein Thrombosis and Pulmonary Embolism in Liver Transplant Patients: Risks and Prevention. Transplant direct. 2016;2(4):e68. 85. Peiris P, Pai S-L, Aniskevich S, Crawford CC, Torp KD, Ladlie BL, et al. Intracardiac thrombosis during liver transplant: A 17-year single-institution study. Liver Transplant. 2015 Oct;21(10):1280–5. 86. Xia VW, Ho JK, Nourmand H, Wray C, Busuttil RW, Steadman RH. Incidental intracardiac thromboemboli during liver transplantation: Incidence, risk factors, and management. Liver Transplant. 2010;16(12):1421–7. 87. Sakai T, Matsusaki T, Dai F, Tanaka KA, Donaldson JB, Hilmi IA, et al. Pulmonary thromboembolism during adult liver transplantation: incidence, clinical presentation, outcome, risk factors, and diagnostic predictors. Br J Anaesth. 2012 Mar 1;108(3):469–77. 88. Warnaar N, Molenaar IQ, Colquhoun SD, Slooff MJH, Sherwani S, De Wolf AM, et al. Intraoperative pulmonary embolism and intracardiac thrombosis complicating liver transplantation: A systematic review. J Thromb Haemost. 2008;6(2):297–302. 89. Kappa SF, Gorden DL, Davidson MA, Wright JK, Guillamondegui OD. Intraoperative blood loss predicts hemorrhage-related reoperation after orthotopic liver transplantation. Am Surg. 2010 Sep;76(9):969–73. 90. Massicotte L, Lenis S, Thibeault L, Sassine M-P, Seal RF, Roy A. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations. Liver Transplant. 2006 Jan;12(1):117–23. 91. Li Z, Sun YM, Wu FX, Yang LQ, Lu ZJ, Yu WF. Controlled low central venous pressure reduces blood loss and transfusion requirements in hepatectomy. World J Gastroenterol. 2014;20(1):303–9. 92. Larsen JB, Hvas AM. Predictive value of whole blood and plasma coagulation tests for intra- and postoperative bleeding risk: A systematic review. Semin Thromb Hemost. 2017;43(7):772–805. 93. Kirchner C, Dirkmann D, Treckmann JW, Paul A, Hartmann M, Saner FH, et al. Coagulation management with factor concentrates in liver transplantation: A single- center experience. Transfusion. 2014;54(1):2760–8. 94. Chavez-Tapia NC, Alfaro-Lara R, Tellez-Avila F, Barrientos-Gutiérrez T, González-Chon O, Mendez-Sanchez N, et al. Prophylactic activated recombinant factor VII in liver resection and liver transplantation: Systematic review and meta-analysis. PLoS One. 2011;6(7):1–8. 95. Lisman T, Porte RJ. Recombinant factor VIIa to treat severe bleeding in patients with liver disease: Pitfalls and possibilities. J Hepatol. 2011;55(4):950–1.

RkJQdWJsaXNoZXIy ODAyMDc0